racemetirosine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

racemetirosine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagchi, SP1
Bruckwick, E; Lovenberg, W; Schmidt, CJ1
Fuller, RW; Hemrick-Luecke, SK1
Cheng, JT; Lin, YS; Tsao, CW1
Jenner, P; Smith, LA; Treseder, SA1
Feldon, J; Ferger, B; Hengerer, B; Leng, A; Mura, A1
Barroso-Chinea, P; Berthet, A; Bezard, E; Canron, MH; Charron, G; Delalande, F; Doudnikoff, E; Giros, B; Goumon, Y; Laux, A; Li, Q; Nosten-Bertrand, M; Porras, G; Qin, C; Van Dorsselaer, A; Vital, A1
Khakimova, GR; Kozina, EA; Kucheryanu, VG; Ugrumov, MV1

Other Studies

8 other study(ies) available for racemetirosine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ArticleYear
Reserpine induced intraneuronal dopamine oxidation: reversal by MPP+ action.
    Life sciences, 1991, Volume: 48, Issue:10

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; alpha-Methyltyrosine; Animals; Dopamine; Methyltyrosines; Mice; Mice, Inbred Strains; Nerve Endings; Neurons; Oxidation-Reduction; Reserpine; Synaptosomes; Tyrosine; Tyrosine 3-Monooxygenase

1991
Lack of evidence supporting a role for dopamine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
    European journal of pharmacology, 1985, Jul-11, Volume: 113, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Methyltyrosine; Animals; Dopamine; Levodopa; Male; Methyltyrosines; Mice; Neurons; Pyridines; Receptors, Dopamine; Tyrosine 3-Monooxygenase

1985
Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Research communications in chemical pathology and pharmacology, 1985, Volume: 48, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; alpha-Methyltyrosine; Animals; Corpus Striatum; Dopamine; Haloperidol; Male; Methyltyrosines; Mice; Mice, Inbred Strains; Nalidixic Acid; Naphthyridines; Pyridines

1985
Inhibition of immune cell proliferation with haloperidol and relationship of tyrosine hydroxylase expression to immune cell growth.
    Life sciences, 1998, Volume: 62, Issue:21

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Methyltyrosine; Animals; Cell Division; Dopamine Agents; Dopamine Antagonists; Enzyme Inhibitors; Flow Cytometry; Gene Expression; Haloperidol; Humans; Hybridomas; Mice; PC12 Cells; Rats; T-Lymphocytes; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase

1998
Endogenous dopaminergic tone and dopamine agonist action.
    Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Apomorphine; Benzopyrans; Callithrix; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Levodopa; Locomotion; Male; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Tyrosine 3-Monooxygenase

2000
Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Behavioural brain research, 2004, Oct-05, Volume: 154, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Analysis of Variance; Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Homovanillic Acid; Immunohistochemistry; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Running; Time Factors; Tyrosine 3-Monooxygenase

2004
Endogenous morphine-like compound immunoreactivity increases in parkinsonism.
    Brain : a journal of neurology, 2011, Volume: 134, Issue:Pt 8

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; alpha-Methyltyrosine; Analysis of Variance; Animals; Brain; Choline O-Acetyltransferase; Chromatography, High Pressure Liquid; Dendrites; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Functional Laterality; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutamate Decarboxylase; Humans; Levodopa; Macaca fascicularis; Male; Medial Forebrain Bundle; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Immunoelectron; Middle Aged; Nerve Growth Factors; Organic Chemicals; Oxidopamine; Parkinsonian Disorders; Postmortem Changes; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Tandem Mass Spectrometry

2011
Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson's Disease.
    Molecular neurobiology, 2017, Volume: 54, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Methyltyrosine; Animals; Catecholamines; Early Diagnosis; Male; Mice, Inbred C57BL; Models, Biological; Motor Activity; Neostriatum; Nerve Fibers; Parkinson Disease; Substantia Nigra; Tyrosine 3-Monooxygenase

2017